Skip to main content
Media Coverage

A Pioneering Push in Cancer Treatment: Enveric Biosciences Advances with Cannabinoid Therapies [Microdose]

By May 8, 2024No Comments

Enveric Biosciences, a notable player in biotechnological innovations, has recently announced a significant licensing agreement that might change the landscape of cancer treatment. According to a recent press release from the company, a non-binding term sheet has been signed with an undisclosed licensee, aiming to use patented methods that incorporate cannabinoids with chemotherapeutic drugs to treat breast and other types of cancer.

Full Article >>